Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,172 | -37,230 | -22,830 | -8,547 | -3,597 |
| Depreciation Amortization | 625 | 2,311 | 1,623 | 869 | 339 |
| Income taxes - deferred | N/A | 164 | N/A | N/A | N/A |
| Accounts receivable | N/A | 5,343 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | -4,354 | N/A | N/A | N/A |
| Other Working Capital | -9,724 | -16,377 | -14,792 | -20,250 | -13,455 |
| Other Operating Activity | 1,133 | 4,247 | 3,520 | 3,019 | 1,582 |
| Operating Cash Flow | $-12,138 | $-45,896 | $-32,479 | $-24,909 | $-15,131 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -28 | -2,726 | -2,148 | -2,988 | -1,927 |
| Purchase Of Investment | N/A | -41,499 | -41,178 | -38,525 | -26,032 |
| Sale Of Investment | N/A | 83,437 | 67,687 | 47,523 | 28,373 |
| Investing Cash Flow | $-28 | $39,212 | $24,361 | $6,010 | $414 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,693 | 10,115 | 10,040 | 416 | N/A |
| Financing Cash Flow | $9,693 | $10,115 | $10,040 | $416 | $N/A |
| Exchange Rate Effect | -1,128 | 4,745 | 2,708 | 525 | -112 |
| Beginning Cash Position | 70,436 | 62,260 | 62,260 | 62,260 | 62,260 |
| End Cash Position | 66,835 | 70,436 | 66,890 | 44,302 | 47,431 |
| Net Cash Flow | $-3,601 | $8,176 | $4,630 | $-17,958 | $-14,829 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,138 | -45,896 | -32,479 | -24,909 | -15,131 |
| Capital Expenditure | -28 | -2,726 | -2,148 | -2,988 | -1,927 |
| Free Cash Flow | -12,166 | -48,622 | -34,627 | -27,897 | -17,058 |